Inhibition_NN of_IN Squalene_NP Synthase_NP and_CC Squalene_NP Epoxidase_NN in_IN Tobacco_NP Cells_NP Triggers_NP an_DT Up-Regulation_NN of_IN 3-Hydroxy-3-Methylglutaryl_JJ Coenzyme_NP A_NP Reductase_NP To_TO get_VB some_DT insight_NN into_IN the_DT regulatory_JJ mechanisms_NNS controlling_VBG the_DT sterol_NN branch_NN of_IN the_DT mevalonate_JJ pathway_NN ,_, tobacco_NN (_( Nicotiana_NP tabacum_NP cv_NP Bright_NP Yellow-2_NP )_) cell_NN suspensions_NNS were_VBD treated_VBN with_IN squalestatin-1_NN and_CC terbinafine_NN ,_, two_CD specific_JJ inhibitors_NNS of_IN squalene_NN synthase_NN (_( SQS_NP )_) and_CC squalene_NN epoxidase_NN ,_, respectively_RB ._SENT These_DT two_CD enzymes_NNS catalyze_VBP the_DT first_JJ two_CD steps_NNS involved_VBN in_IN sterol_NN biosynthesis_NN ._SENT In_IN highly_RB dividing_VBG cells_NNS ,_, SQS_NP was_VBD actively_RB expressed_VBN concomitantly_RB with_IN 3-hydroxy-3-methylglutaryl_JJ coenzyme_NN A_DT reductase_NN and_CC both_DT sterol_NN methyltransferases_NNS ._SENT At_IN nanomolar_NN concentrations_NNS ,_, squalestatin_NN was_VBD found_VBN to_TO inhibit_VB efficiently_RB sterol_NN biosynthesis_NN as_IN attested_VBN by_IN the_DT rapid_JJ decrease_NN in_IN SQS_NP activity_NN and_CC [_SYM 14C]radioactivity_NN from_IN acetate_NN incorporated_VBN into_IN sterols_NNS ._SENT A_DT parallel_JJ dose-dependent_NN accumulation_NN of_IN farnesol_NN ,_, the_DT dephosphorylated_JJ form_NN of_IN the_DT SQS_NP substrate_NN ,_, was_VBD observed_VBN without_IN affecting_VBG farnesyl_NN diphosphate_NN synthase_NN steady-state_NN mRNA_NN levels_NNS ._SENT Treatment_NN of_IN tobacco_NN cells_NNS with_IN terbinafine_NN is_VBZ also_RB shown_VBN to_TO inhibit_VB sterol_NN synthesis_NN ._SENT In_IN addition_NN ,_, this_DT inhibitor_NN induced_VBD an_DT impressive_JJ accumulation_NN of_IN squalene_NN and_CC a_DT dose-dependent_JJ stimulation_NN of_IN the_DT triacylglycerol_NN content_NN and_CC synthesis_NN ,_, suggesting_VBG the_DT occurrence_NN of_IN regulatory_JJ relationships_NNS between_IN sterol_NN and_CC triacylglycerol_JJ biosynthetic_JJ pathways_NNS ._SENT We_PP demonstrate_VBP that_IN squalene_NN was_VBD stored_VBN in_IN cytosolic_JJ lipid_NN particles_NNS ,_, but_CC could_MD be_VB redirected_VBN toward_IN sterol_NN synthesis_NN if_IN required_VBN ._SENT Inhibition_NN of_IN either_DT SQS_NP or_CC squalene_NN epoxidase_NN was_VBD found_VBN to_TO trigger_VB a_DT severalfold_JJ increase_NN in_IN enzyme_NN activity_NN of_IN 3-hydroxy-3-methylglutaryl_JJ coenzyme_NN A_DT reductase_NN ,_, giving_VBG first_JJ evidence_NN for_IN a_DT positive_JJ feedback_NN regulation_NN of_IN this_DT key_JJ enzyme_NN in_IN response_NN to_TO a_DT selective_JJ depletion_NN of_IN endogenous_JJ sterols_NNS ._SENT At_IN the_DT same_JJ time_NN ,_, no_DT compensatory_JJ responses_NNS mediated_VBN by_IN SQS_NP were_VBD observed_VBN ,_, in_IN sharp_JJ contrast_NN to_TO the_DT situation_NN in_IN mammalian_JJ cells_NNS ._SENT In_IN higher_JJR plants_NNS ,_, two_CD distinct_JJ pathways_NNS have_VBP been_VBN shown_VBN to_TO operate_VB concomitantly_RB for_IN synthesizing_VBG isopentenyl_NN diphosphate_NN ,_, the_DT common_JJ precursor_NN for_IN all_DT isoprenoids_NNS ._SENT Plastid_NN isoprenoids_NNS such_JJ as_IN carotenoids_NNS ,_, mono-_NN and_CC diterpenes_NNS ,_, or_CC the_DT prenyl_NN chains_NNS of_IN chlorophylls_NNS and_CC plastoquinones_NNS are_VBP formed_VBN from_IN 2-C-methyl-d-erythritol_JJ 4-phosphate_NN ,_, which_WDT itself_PP arises_VBZ from_IN the_DT initial_JJ condensation_NN of_IN pyruvate_NNS with_IN glyceraldehyde_NN 3-phosphate_NN (_( for_IN review_NN ,_, see_VBP ;_: )_) ._SENT In_IN the_DT cytosol_NN ,_, isoprenoids_NNS are_VBP synthesized_VBN via_IN the_DT classical_JJ acetate/mevalonate_NN (_( MVA_NP )_) pathway_NN ,_, in_IN which_WDT 3-hydroxy-3-methylglutaryl_JJ coenzyme_NN A_NP (_( CoA_NP )_) reductase_NN (_( HMGR_NP )_) plays_VBZ a_DT key_JJ role_NN ._SENT This_DT enzyme_NN is_VBZ encoded_VBN by_IN a_DT multigene_JJ family_NN ._SENT In_IN this_DT pathway_NN ,_, farnesyl_NN diphosphate_NN (_( FPP_NP )_) occupies_VBZ a_DT central_JJ position_NN from_IN which_WDT specific_JJ cis-_NNS and_CC trans-prenyltransferases_NNS dispatch_VBP isoprene_NN units_NNS to_TO either_DT sterols_NNS or_CC non-sterol_NN isoprenoids_NNS as_RB represented_VBN by_IN sesquiterpenes_NNS ,_, ubiquinone_NN ,_, heme_NN a_DT ,_, polyprenols_NNS ,_, or_CC prenylated_JJ proteins_NNS ._SENT It_PP has_VBZ been_VBN recently_RB proposed_VBN that_IN specific_JJ classes_NNS of_IN isoprenoids_NNS might_MD be_VB produced_VBN within_IN distinct_JJ metabolic_JJ channels_NNS or_CC metabolons_NNS ,_, probably_RB involving_VBG individual_JJ HMGR_NP isoforms_NNS ._SENT Sterols_NNS represent_VBP the_DT major_JJ end_NN products_NNS of_IN this_DT multibranched_JJ pathway_NN ,_, but_CC what_WP controls_VBZ the_DT whole_JJ pathway_NN is_VBZ still_RB far_RB from_IN being_VBG understood_VBN ._SENT Such_PDT a_DT control_NN might_MD either_RB concern_VB only_JJ branch_NN point_NN enzymes_NNS or_CC involve_VB coordinated_VBN functioning_NN of_IN distinct_JJ metabolic_JJ channels_NNS ,_, each_DT one_NN being_VBG regulated_VBN independently_RB from_IN one_CD another_DT ._SENT Figure_NP 1_CD |_SYM Cytosolic_JJ isoprenoid_JJ biosynthetic_JJ pathway_NN ._SENT Cytosolic_JJ isoprenoid_JJ biosynthetic_JJ pathway_NN ._SENT Cytosolic_JJ isoprenoids_NNS are_VBP synthesized_VBN from_IN acetyl_NN CoA_NP via_IN the_DT intermediate_JJ formation_NN of_IN MVA_NP ._SENT IPP_NP ,_, Isopentenyl_NP diphosphate_NN ;_: DMAPP_NP ,_, dimethylallyl_NN diphosphate_NN ;_: IPA_NP ,_, isopentenyl_NN adenine_NN ;_: and_CC UQ_NP ,_, ubiquinone_NN ._SENT Sq_NP and_CC Tb_NP inhibit_VBP SQS_NP and_CC SE_NP ,_, respectively_RB ._SENT The_DT first_JJ step_NN committed_VBN to_TO the_DT sterol_NN branch_NN of_IN the_DT isoprenoid_JJ pathway_NN is_VBZ catalyzed_VBN by_IN the_DT squalene_NN synthase_NN (_( SQS_NP )_) ,_, which_WDT mediates_VBZ the_DT reductive_JJ head-to-head_NN condensation_NN of_IN two_CD molecules_NNS of_IN FPP_NP to_TO form_VB squalene_NN via_IN presqualene_NN diphosphate_NN ._SENT This_DT reaction_NN takes_VBZ place_NN in_IN membranes_NNS of_IN endoplasmic_JJ reticulum_NN ,_, as_RB do_VBP all_DT subsequent_JJ steps_NNS involved_VBN in_IN sterol_NN biosynthesis_NN ._SENT Because_IN of_IN its_PP$ particular_JJ position_NN at_IN the_DT interface_NN between_IN hydrophilic_JJ and_CC hydrophobic_JJ intermediates_NNS ,_, SQS_NP might_MD constitute_VB a_DT major_JJ control_NN point_NN for_IN regulating_VBG the_DT sterol_NN branch_NN in_IN directing_VBG FPP_NP molecules_NNS into_IN either_DT sterols_NNS or_CC non-sterol_NN isoprenoids_NNS in_IN response_NN to_TO changing_VBG cellular_JJ requirements_NNS ._SENT The_DT sequence_NN of_IN reactions_NNS needed_VBN to_TO convert_VB squalene_NN into_IN end_NN products_NNS is_VBZ now_RB well_RB known_VBN ,_, and_CC the_DT "_`` state_NN of_IN art_NN "_'' on_IN relevant_JJ enzymes_NNS and_CC genes_NNS has_VBZ been_VBN just_RB reviewed_VBN ._SENT In_IN contrast_NN to_TO animal_NN and_CC fungal_JJ cells_NNS ,_, higher_JJR plants_NNS synthesize_VBP a_DT mixture_NN of_IN sterols_NNS in_IN which_WDT sitosterol_NN ,_, stigmasterol_NN ,_, and_CC 24-methylcholesterol_JJ often_RB predominate_VB ._SENT These_DT compounds_NNS play_VBP an_DT essential_JJ role_NN as_IN membrane_NN components_NNS in_IN regulating_VBG the_DT fluidity_NN and_CC permeability_NN of_IN membranes_NNS and_CC the_DT activity_NN of_IN membrane-associated_JJ proteins_NNS ,_, but_CC some_DT sterols_NNS or_CC biosynthetic_JJ intermediates_NNS might_MD also_RB serve_VB as_IN signal_NN molecules_NNS during_IN plant_NN growth_NN and_CC development_NN ._SENT Despite_IN the_DT critical_JJ importance_NN of_IN sterols_NNS ,_, mechanisms_NNS responsible_JJ for_IN sterol_NN homeostasis_NN in_IN higher_JJR plants_NNS are_VBP still_RB largely_RB unknown_JJ ._SENT Recent_JJ reports_NNS have_VBP pointed_VBN out_RP that_IN HMGR_NP could_MD regulate_VB the_DT flux_NN of_IN intermediates_NNS toward_IN the_DT sterol_NN branch_NN ,_, but_CC whether_IN or_CC not_RB this_DT enzyme_NN is_VBZ able_JJ to_TO respond_VB to_TO a_DT depletion_NN of_IN sterol_NN end_NN products_NNS had_VBD not_RB yet_RB been_VBN investigated_VBN until_IN now_RB ._SENT To_TO get_VB some_DT insight_NN into_IN the_DT regulatory_JJ mechanisms_NNS controlling_VBG the_DT sterol_NN biosynthetic_JJ pathway_NN ,_, the_DT present_JJ study_NN was_VBD focused_VBN on_IN the_DT role_NN played_VBN by_IN the_DT plant_NN SQS_NP ._SENT Early_JJ work_NN with_IN plant_NN cell_NN suspension_NN cultures_NNS has_VBZ already_RB emphasized_VBN its_PP$ involvement_NN in_IN plant_NN defense_NN reactions_NNS ._SENT A_DT very_RB fast_JJ inhibition_NN of_IN SQS_NP activity_NN was_VBD observed_VBN after_IN addition_NN of_IN fungal_JJ elicitors_NNS ._SENT The_DT resulting_VBG arrest_NN of_IN sterol_NN biosynthesis_NN has_VBZ been_VBN interpreted_VBN as_IN a_DT means_NN for_IN the_DT cell_NN to_TO either_RB redirect_VB metabolic_JJ intermediates_NNS ,_, especially_RB FPP_NP ,_, toward_IN the_DT synthesis_NN of_IN sesquiterpene_NN phytoalexins_NNS or_CC simply_RB to_TO leave_VB "_`` house-keeping_JJ "_'' metabolism_NN pending_VBG better_JJR conditions_NNS ._SENT This_DT work_NN was_VBD aimed_VBN at_IN probing_VBG the_DT effects_NNS of_IN a_DT direct_JJ inhibition_NN of_IN SQS_NP in_IN tobacco_NN (_( Nicotiana_NP tabacum_NP cv_NP Bright_NP Yellow-2_NP [_SYM TBY-2_NP ]_SYM )_) cell_NN suspension_NN cultures_NNS ._SENT The_DT recent_JJ availability_NN of_IN squalestatins_NNS (_( also_RB called_VBN zaragozic_NN acids_NNS )_) ,_, which_WDT are_VBP highly_RB potent_JJ and_CC specific_JJ inhibitors_NNS of_IN SQS_NP ,_, gives_VBZ the_DT opportunity_NN to_TO investigate_VB whether_IN or_CC not_RB compensatory_JJ responses_NNS take_VBP place_NN in_IN the_DT case_NN of_IN a_DT depletion_NN of_IN only_JJ squalene-derived_JJ products_NNS ._SENT In_IN particular_JJ ,_, we_PP wanted_VBD to_TO check_VB the_DT possibility_NN for_IN HMGR_NP to_TO be_VB a_DT target_NN for_IN positive_JJ feedback_NN regulation_NN by_IN endogenous_JJ sterols_NNS ._SENT Our_PP$ study_NN also_RB comprises_VBZ an_DT investigation_NN of_IN responses_NNS of_IN TBY-2_JJ cells_NNS to_TO an_DT inhibition_NN of_IN squalene_NN epoxidase_NN (_( SE_NP )_) ,_, the_DT next_JJ committed_JJ enzyme_NN to_TO the_DT sterol_NN pathway_NN ._SENT This_DT enzyme_NN catalyzes_VBZ the_DT stereospecific_JJ conversion_NN of_IN squalene_NN to_TO (3S)-2,3-oxidosqualene_NN in_IN the_DT presence_NN of_IN molecular_JJ oxygen_NN ._SENT It_PP is_VBZ the_DT first_JJ oxygen-requiring_NN step_NN in_IN the_DT sterol_NN biosynthetic_JJ pathway_NN and_CC ,_, thus_RB ,_, might_MD constitute_VB a_DT secondary_JJ regulatory_JJ level_NN ._SENT SE_FW can_MD be_VB specifically_RB inhibited_VBN by_IN compounds_NNS belonging_VBG to_TO the_DT class_NN of_IN allylamines_NNS ._SENT Here_RB ,_, we_PP show_VBP that_IN both_DT squalestatin-1_JJ (_( Sq_NP )_) and_CC terbinafine_NP (_( Tb_NP )_) are_VBP able_JJ to_TO inhibit_VB efficiently_RB sterol_NN biosynthesis_NN in_IN TBY-2_JJ cells_NNS and_CC ,_, thus_RB ,_, to_TO induce_VB a_DT decrease_NN in_IN the_DT sterol_NN cell_NN content_NN ._SENT In_IN the_DT case_NN of_IN Tb_NP treatment_NN ,_, this_DT depletion_NN was_VBD accompanied_VBN by_IN a_DT concomitant_JJ accumulation_NN of_IN squalene_NN and_CC by_IN an_DT increase_NN in_IN the_DT content_NN and_CC the_DT rate_NN of_IN synthesis_NN of_IN triacylglycerols_NNS (_( TAG_NP )_) ._SENT Squalene_NN was_VBD found_VBN to_TO accumulate_VB in_IN lipid_NN droplets_NNS but_CC could_MD be_VB redirected_VBN toward_IN sterol_NN biosynthesis_NN if_IN necessary_JJ ._SENT Our_PP$ results_NNS demonstrate_VBP that_IN inhibition_NN of_IN either_DT SQS_NP or_CC SE_NP triggers_VBZ an_DT increase_NN in_IN HMGR_NP enzyme_NN activity_NN ,_, giving_VBG evidence_NN for_IN a_DT positive_JJ feedback_NN regulation_NN of_IN this_DT key_JJ enzyme_NN in_IN response_NN to_TO a_DT selective_JJ depletion_NN of_IN endogenous_JJ sterols_NNS ._SENT Surprisingly_RB ,_, we_PP observed_VBD no_DT compensatory_JJ responses_NNS mediated_VBN by_IN SQS_NP ,_, in_IN sharp_JJ contrast_NN to_TO the_DT situation_NN in_IN animal_JJ systems_NNS ._SENT Sterol_NN Enzyme_NP Activities_NP and_CC Free_NP Sterol_NP Levels_NP during_IN a_DT Growth_NP Cycle_NP of_IN TBY-2_NP Cells_NP |_SYM Figure_NN shows_VBZ a_DT typical_JJ growth_NN curve_NN of_IN a_DT TBY-2_NP cell_NN culture_NN and_CC the_DT corresponding_JJ changes_NNS in_IN four_CD sterol_NN enzyme_NN activities_NNS and_CC in_IN free_JJ sterol_NN levels_NNS ._SENT Microsomal_JJ fractions_NNS were_VBD prepared_VBN from_IN cultures_NNS collected_VBN on_IN the_DT designated_VBN days_NNS after_IN subculturing_VBG and_CC used_VBN for_IN both_DT enzymatic_JJ assays_NNS and_CC sterol_NN determinations_NNS ._SENT We_PP monitored_VBD SQS_NP activity_NN and_CC the_DT activities_NNS of_IN HMGR_NP and_CC sterol_NN methyltransferases_NNS SMT1_NP and_CC SMT2_NP throughout_IN the_DT growth_NN cycle_NN ._SENT HMGR_NP ,_, an_DT upstream_JJ enzyme_NN ,_, is_VBZ involved_VBN in_IN the_DT synthesis_NN of_IN both_DT sterols_NNS and_CC non-sterol_NN isoprenoids_NNS ._SENT Sterol_NN methyltransferases_NNS catalyze_VBP two_CD distinct_JJ steps_NNS downstream_JJ of_IN squalene_NN :_: the_DT S-adenosyl-l-Met-dependent_JJ methylation_NN of_IN cycloartenol_NN (_( SMT1_NP )_) and_CC of_IN 24-methylenelophenol_JJ (_( SMT2_NP )_) to_TO give_VB 24-methylenecycloartanol_JJ and_CC 24-ethylidenelophenol_JJ ,_, respectively_RB ._SENT Figure_NP 2_CD |_SYM Sterol_NN biosynthesis_NN in_IN proliferating_VBG TBY-2_JJ cells_NNS :_: changes_NNS in_IN cell_NN mass_NN (_( A_NP )_) ,_, sterol_NN enzyme_NN activities_NNS (_( B_NP )_) ,_, and_CC free_JJ 4-demethylsterol_JJ levels_NNS (_( C_NP )_) as_IN a_DT function_NN of_IN time_NN after_IN subculturing_VBG ._SENT Sterol_NN biosynthesis_NN in_IN proliferating_VBG TBY-2_JJ cells_NNS :_: changes_NNS in_IN cell_NN mass_NN (_( A_NP )_) ,_, sterol_NN enzyme_NN activities_NNS (_( B_NP )_) ,_, and_CC free_JJ 4-demethylsterol_JJ levels_NNS (_( C_NP )_) as_IN a_DT function_NN of_IN time_NN after_IN subculturing_VBG ._SENT Microsomal_JJ membranes_NNS were_VBD prepared_VBN from_IN cultures_NNS collected_VBN on_IN the_DT designated_VBN days_NNS after_IN subculturing_VBG and_CC used_VBN for_IN both_DT measurements_NNS of_IN sterol_NN enzyme_NN activities_NNS (_( the_DT values_NNS are_VBP the_DT means_NN of_IN two_CD replicates_VBZ and_CC are_VBP representative_JJ of_IN a_DT standard_JJ experiment_NN )_) and_CC free_JJ 4-demethylsterol_JJ contents_NNS (_( +-se_NN )_) ._SENT SMT1_NP ,_, S-adenosyl_NP Met-cycloartenol_NP methyltransferase_NN ;_: and_CC SMT2_NP ,_, S-adenosyl_NP Met-24-methylenelophenol_NP methyltransferase_NN ._SENT One_CD or_CC 2_CD d_NN after_IN subculturing_VBG ,_, the_DT tobacco_NN cell_NN culture_NN entered_VBN into_IN a_DT rapid_JJ growth_NN phase_NN ,_, as_RB attested_VBN by_IN a_DT large_JJ increase_NN in_IN fresh_JJ cell_NN mass_NN ,_, and_CC reached_VBD a_DT stationary_JJ phase_NN after_IN 7_CD d_NN (_( Fig._NN A_NP )_) ._SENT Activities_NNS of_IN the_DT four_CD enzymes_NNS exhibited_VBN very_RB similar_JJ changes_NNS over_IN the_DT course_NN of_IN a_DT culture_NN cycle_NN ,_, with_IN a_DT maximum_NN found_VBN on_RB d_SYM 5_CD and_CC a_DT sharp_JJ decrease_NN in_IN the_DT stationary_JJ phase_NN ,_, suggesting_VBG a_DT coordinated_VBN expression_NN of_IN all_PDT the_DT enzymes_NNS of_IN the_DT sterol_NN pathway_NN in_IN proliferating_VBG TBY-2_JJ cells_NNS (_( Fig._NN B_NN )_) ._SENT In_IN Figure_NP C_NP ,_, changes_NNS in_IN the_DT sterol_NN levels_NNS over_IN the_DT growth_NN cycle_NN are_VBP given_VBN ._SENT Only_JJ free_JJ Delta5-sterols_NNS ,_, the_DT end_NN products_NNS of_IN the_DT pathway_NN ,_, were_VBD quantified_VBN (_( as_IN micrograms_NNS per_IN milligram_NN of_IN protein_NN )_) ._SENT As_IN expected_VBN ,_, these_DT compounds_NNS mainly_RB accumulated_VBN in_IN the_DT stationary_JJ phase_NN ._SENT The_DT sterol_NN composition_NN of_IN 3-d-old_JJ TBY-2_NP cells_NNS is_VBZ given_VBN in_IN Table_NP ._SENT Stigmasterol_NN ,_, 24-methylcholesterol_JJ and_CC sitosterol_NN were_VBD by_IN far_RB the_DT predominant_JJ sterols_NNS ._SENT The_DT other_JJ sterols_NNS were_VBD isofucosterol_JJ ,_, 24-methylenecholesterol_JJ ,_, cholesterol_NN ,_, and_CC Delta7-cholesterol_NP ._SENT Other_JJ compounds_NNS (_( about_RB 1.2_CD %_NN of_IN total_JJ sterols_NNS )_) represented_VBD the_DT usual_JJ sterol_NN biosynthetic_JJ intermediates_NNS :_: 4alpha-methylsterols_NNS (_( obtusifoliol_NP ,_, cycloeucalenol_NN ,_, 24-methylene-_JJ ,_, and_CC 24-ethylidenelophenol_JJ )_) and_CC 4,4-dimethylsterols_JJ (_( cycloartenol_NN and_CC 24-methylenecycloartanol_JJ )_) ._SENT The_DT relative_JJ proportions_NNS of_IN the_DT different_JJ end_NN products_NNS were_VBD found_VBN not_RB to_TO change_VB over_IN the_DT growth_NN cycle_NN ,_, with_IN the_DT exception_NN of_IN a_DT slight_JJ increase_NN (_( from_IN 1.55_CD to_TO 1.82_CD )_) in_IN the_DT ratio_NN of_IN stigmasterol_NN to_TO sitosterol_NN (_( data_NNS not_RB shown_VBN )_) ._SENT Table_NP I_NP |_SYM Free_JJ sterol_NN composition_NN of_IN TBY-2_NP cells_NNS Effects_NNS of_IN Sq_NP |_SYM Cell_JJ Growth_NN ,_, Sterol_NP Content_NP ,_, and_CC Biosynthesis_NP |_SYM Three-day-old_JJ TBY-2_NP cells_NNS were_VBD treated_VBN with_IN concentrations_NNS of_IN Sq_NP ranging_VBG from_IN 0_CD to_TO 0.5_CD mum_NN for_IN 24_CD h_NN and_CC incubated_VBN with_IN radioactive_JJ sodium_NN acetate_NN for_IN 2_CD h_NN just_RB before_IN cell_NN harvesting_NN ._SENT TBY-2_JJ cells_NNS were_VBD collected_VBN by_IN filtration_NN and_CC analyzed_VBD for_IN their_PP$ sterol_NN composition_NN as_RB described_VBD in_RP "_`` Materials_NPS and_CC Methods_NP ._SENT "_`` Sterols_NNS (_( as_IN the_DT sum_NN of_IN free_JJ and_CC esterified_VBN forms_NNS )_) were_VBD quantified_VBN by_IN gas_NN chromatography_NN (_( GC_NP )_) as_IN acetate_NN derivatives_NNS ._SENT Table_NN shows_VBZ that_IN Sq_NP severely_RB impaired_VBD cell_NN growth_NN as_IN attested_VBN by_IN a_DT 50_CD %_NN decrease_NN in_IN the_DT cell_NN mass_NN after_IN a_DT treatment_NN with_IN 0.5_CD mum_NN ._SENT A_DT parallel_JJ dose-dependent_NN decrease_NN in_IN the_DT sterol_NN cell_NN content_NN was_VBD found_VBN ._SENT The_DT high_JJ sensitivity_NN of_IN TBY-2_JJ cells_NNS toward_IN the_DT inhibitor_NN is_VBZ illustrated_VBN by_IN the_DT very_RB fast_JJ depletion_NN of_IN the_DT pool_NN of_IN 4,4-dimethylsterols_NNS ,_, the_DT early_JJ precursors_NNS of_IN sterols_NNS ,_, which_WDT was_VBD reduced_VBN by_IN 88_CD %_NN after_IN a_DT treatment_NN with_IN only_RB 50_CD nm_NN Sq_NP (_( data_NN not_RB shown_VBN )_) ._SENT The_DT efficiency_NN of_IN Sq_NP as_IN an_DT inhibitor_NN of_IN the_DT sterol_NN pathway_NN was_VBD confirmed_VBN by_IN measurements_NNS of_IN radioactivity_NN from_IN [_SYM 14C]acetate_JJ incorporated_VBN into_IN end_NN products_NNS ._SENT After_IN addition_NN of_IN 50_CD nm_NN Sq_NP ,_, radioactivity_NN associated_VBN with_IN 4-demethylsterols_NNS accounted_VBN for_IN only_RB 4_CD %_NN compared_VBN with_IN that_DT of_IN sterols_NNS from_IN control_NN cells_NNS ._SENT At_IN the_DT same_JJ time_NN ,_, a_DT dose-dependent_JJ accumulation_NN of_IN a_DT labeled_VBN compound_NN was_VBD observed_VBN ._SENT This_DT compound_NN ,_, which_WDT was_VBD recovered_VBN in_IN the_DT band_NN corresponding_JJ to_TO 4alpha-methylsterols_NNS ,_, was_VBD identified_VBN as_IN farnesol_NN ._SENT It_PP might_MD originate_VB from_IN hydrolysis_NN of_IN radioactive_JJ FPP_NP molecules_NNS not_RB used_VBN for_IN sterol_NN synthesis_NN ._SENT Table_NP II_NP |_SYM Effect_NN of_IN Sq_NP on_IN cell_NN growth_NN ,_, sterol_NN biosynthesis_NN ,_, and_CC SQS_NP activity_NN SQS_NP Activity_NP |_SYM The_DT target_NN of_IN Sq_NP is_VBZ SQS_NP as_RB illustrated_VBD in_IN Table_NP ._SENT A_DT dose_NN as_IN low_JJ as_IN 50_CD nm_NN Sq_NP was_VBD shown_VBN to_TO be_VB sufficient_JJ to_TO inhibit_VB almost_RB completely_RB SQS_NP activity_NN in_IN microsomal_JJ fractions_NNS ._SENT Such_PDT an_DT inhibition_NN was_VBD found_VBN to_TO take_VB place_NN in_IN a_DT few_JJ hours_NNS ,_, with_IN an_DT IC50_NP value_NN of_IN 5.5_CD nm_NN ,_, indicating_VBG the_DT very_RB potent_JJ inhibitory_JJ power_NN of_IN Sq_NP ._SENT This_DT compound_NN ,_, which_WDT partially_RB mimics_VBZ the_DT structure_NN of_IN FPP_NP and/or_CC presqualene_NN diphosphate_NN ,_, has_VBZ been_VBN described_VBN as_IN a_DT competitive_JJ inhibitor_NN of_IN SQS_NP ._SENT Attempts_NNS were_VBD made_VBN to_TO recover_VB SQS_NP activity_NN in_IN microsomal_JJ membranes_NNS from_IN Sq-treated_JJ cells_NNS ._SENT However_RB ,_, neither_DT extensive_JJ washes_VBZ of_IN intact_JJ cells_NNS nor_CC dilution_NN and_CC additional_JJ centrifugations_NNS of_IN microsomes_NNS were_VBD successful_JJ ,_, suggesting_VBG that_IN Sq_NP also_RB acts_VBZ as_IN a_DT mechanism-based_JJ irreversible_JJ inactivator_NN of_IN plant_NN SQS_NP ._SENT SQS_NP ,_, FPP_NP Synthase_NP (_( FPPS_NP )_) ,_, and_CC HMGR_NP Expression_NP |_SYM To_TO investigate_VB whether_IN SQS_NP transcription_NN could_MD be_VB affected_VBN by_IN the_DT inhibition_NN of_IN SQS_NP activity_NN ,_, total_JJ RNA_NP was_VBD isolated_VBN from_IN TBY-2_JJ cells_NNS treated_VBN with_IN different_JJ Sq_NP concentrations_NNS ._SENT A_DT full-length_JJ SQS_NP cDNA_NN from_IN Nicotiana_NP benthamiana_NP ,_, which_WDT has_VBZ 98_CD %_NN identity_NN with_IN the_DT corresponding_JJ N._NP tabacum_NN cDNA_NN ,_, was_VBD used_VBN as_IN a_DT probe_NN ._SENT After_IN hybridization_NN with_IN this_DT probe_NN ,_, transcripts_NNS with_IN a_DT size_NN of_IN 1.6_CD kb_NN could_MD be_VB detected_VBN ._SENT As_IN shown_VBN in_IN Figure_NP B_NP ,_, the_DT levels_NNS of_IN SQS_NP transcripts_NNS were_VBD not_RB found_VBN to_TO change_VB significantly_RB ,_, despite_IN an_DT almost_RB complete_JJ inhibition_NN of_IN SQS_NP activity_NN ._SENT A_DT time-course_NN study_NN (_( from_IN 0_CD to_TO 48_CD h_NN )_) of_IN effects_NNS induced_VBN by_IN 0.5_CD mum_JJ Sq_NP also_RB showed_VBD no_DT differences_NNS between_IN SQS_NP mRNA_NP levels_NNS from_IN control_NN and_CC treated_VBN cells_NNS ,_, whatever_WDT the_DT period_NN of_IN time_NN (_( Fig._NN B_NN )_) ._SENT Because_IN SQS_NP inhibition_NN possibly_RB induces_VBZ an_DT increased_VBN amount_NN of_IN FPP_NP molecules_NNS in_IN the_DT cytosol_NN ,_, we_PP checked_VBD the_DT effects_NNS of_IN Sq_NP treatments_NNS on_IN the_DT transcription_NN of_IN FPPS_NP ._SENT Northern-blot_NP experiments_NNS were_VBD performed_VBN with_IN a_DT partial_JJ FPPS_NP cDNA_NN from_IN TBY-2_JJ cells_NNS as_IN a_DT probe_NN ._SENT The_DT corresponding_JJ mRNA_NN levels_NNS ,_, with_IN a_DT size_NN of_IN about_RB 1.7_CD kb_NN ,_, remained_VBD constant_JJ whatever_WDT the_DT dose_NN of_IN Sq_NP used_VBD ,_, suggesting_VBG that_IN FPPS_NP transcription_NN was_VBD neither_RB affected_VBN by_IN SQS_NP inhibition_NN ,_, nor_CC by_IN the_DT excess_NN of_IN farnesol_NN and_CC FPP_NP ._SENT Figure_NP 3_CD |_SYM Effects_VBZ of_IN Sq_NP on_IN HMGR_NP activity_NN (_( A_NP )_) and_CC HMGR_NP ,_, SQS_NP ,_, and_CC FPPS_NP mRNA_NP levels_NNS (_( B_NP )_) ._SENT Effects_NNS of_IN Sq_NP on_IN HMGR_NP activity_NN (_( A_NP )_) and_CC HMGR_NP ,_, SQS_NP ,_, and_CC FPPS_NP mRNA_NP levels_NNS (_( B_NP )_) ._SENT Three-day-old_JJ TBY-2_NP cells_NNS were_VBD treated_VBN with_IN various_JJ concentrations_NNS of_IN Sq_NP (_( from_IN 0_CD to_TO 500_CD nm_NN )_) and_CC used_VBN to_TO isolate_VB both_DT microsomal_JJ fractions_NNS and_CC total_JJ RNA_NP ._SENT A_DT ,_, HMGR_NP activity_NN was_VBD measured_VBN in_IN the_DT presence_NN of_IN 30_CD mumR,S-[3-14C]HMG-CoA_NN and_CC of_IN 30_CD mug_NN of_IN microsomal_JJ protein_NN ._SENT Control_NN value_NN (_( 5.5_CD nmol_NN h-1_JJ mg-1_NN )_) was_VBD set_VBN at_IN 1_CD ._SENT Enzyme_NN activities_NNS were_VBD expressed_VBN as_IN relative_JJ values_NNS to_TO the_DT control_NN ._SENT Results_NNS are_VBP from_IN two_CD independent_JJ experiments_NNS +-_NN sd_NN ._SENT B_NP ,_, Total_NP RNA_NP (_( 30_CD mug_NN )_) was_VBD loaded_VBN per_IN lane_NN and_CC transferred_VBN to_TO a_DT nylon_NN membrane_NN ._SENT Hybridizations_NNS were_VBD performed_VBN with_IN 32P-labeled_JJ probes_NNS ._SENT All_DT of_IN the_DT hybridizations_NNS were_VBD performed_VBN on_IN the_DT same_JJ membrane_NN ._SENT Relative_JJ intensities_NNS obtained_VBN by_IN PhosphorImage_NP analysis_NN are_VBP given_VBN in_IN the_DT table_NN after_IN correction_NN for_IN background_NN and_CC normalization_NN relatively_RB to_TO EF1-alpha_NP mRNA_NP content_NN ._SENT Control_NN value_NN was_VBD set_VBN at_IN 1_CD ._SENT Figure_NP 4_CD |_SYM Time_NN course_NN of_IN Sq_NP effects_NNS on_IN HMGR_NP activity_NN (_( A_NP )_) and_CC HMGR_NP and_CC SQS_NP mRNA_NP levels_NNS (_( B_NP )_) ._SENT Time_NN course_NN of_IN Sq_NP effects_NNS on_IN HMGR_NP activity_NN (_( A_NP )_) and_CC HMGR_NP and_CC SQS_NP mRNA_NP levels_NNS (_( B_NP )_) ._SENT Three-day-old_JJ TBY-2_NP cells_NNS were_VBD treated_VBN during_IN various_JJ times_NNS (_( from_IN 0_CD to_TO 48_CD h_NN )_) by_IN Sq_NP (_( 500_CD nm_NN )_) and_CC were_VBD used_VBN to_TO isolate_VB both_DT microsomal_JJ fractions_NNS and_CC total_JJ RNA_NP ._SENT A_DT ,_, HMGR_NP activity_NN was_VBD measured_VBN as_IN indicated_VBN in_IN Figure_NP ._SENT For_IN each_DT time_NN ,_, enzyme_NN activities_NNS were_VBD expressed_VBN as_IN relative_JJ values_NNS to_TO the_DT corresponding_JJ control_NN (_( set_VBN at_IN 1_CD )_) ._SENT Results_NNS are_VBP from_IN two_CD independent_JJ experiments_NNS +-_NN sd_NN ._SENT B_NP ,_, Total_NP RNA_NP (_( 30_CD mug_NN )_) was_VBD loaded_VBN per_IN lane_NN and_CC transferred_VBN to_TO a_DT nylon_NN membrane_NN ._SENT Hybridizations_NNS were_VBD performed_VBN with_IN 32P-labeled_JJ probes_NNS ._SENT All_PDT the_DT hybridizations_NNS were_VBD performed_VBN on_IN the_DT same_JJ membrane_NN ._SENT Relative_JJ intensities_NNS obtained_VBN by_IN PhosphorImage_NP analysis_NN are_VBP given_VBN in_IN the_DT table_NN after_IN correction_NN for_IN background_NN and_CC normalization_NN relatively_RB to_TO EF1-alpha_NP mRNA_NP content_NN and_CC compared_VBN with_IN the_DT corresponding_JJ control_NN (_( set_VBN at_IN 1_CD )_) ._SENT It_PP is_VBZ well_RB known_VBN that_IN HMGR_NP constitutes_VBZ the_DT major_JJ limiting-step_NN in_IN cholesterol_NN biosynthesis_NN in_IN mammalian_JJ cells_NNS ._SENT The_DT inhibition_NN of_IN SQS_NP and_CC the_DT resulting_VBG depletion_NN of_IN squalene-derived_JJ products_NNS were_VBD shown_VBN to_TO induce_VB compensatory_JJ responses_NNS mediated_VBN by_IN HMGR_NP ._SENT It_PP seemed_VBD interesting_JJ to_TO us_PP to_TO investigate_VB whether_IN similar_JJ responses_NNS could_MD also_RB take_VB place_NN in_IN TBY-2_JJ cells_NNS ._SENT Three-day-old_JJ TBY-2_NP cells_NNS were_VBD treated_VBN for_IN 24_CD h_NN with_IN Sq_NP concentrations_NNS varying_VBG from_IN 0_CD to_TO 0.5_CD mum_NN and_CC were_VBD used_VBN to_TO isolate_VB both_DT total_JJ RNA_NP and_CC microsomal_JJ fractions_NNS ,_, for_IN HMGR_NP activity_NN measurements_NNS ._SENT As_IN shown_VBN in_IN Figure_NP A_NP ,_, microsomal_JJ fractions_NNS from_IN Sq-treated_NP TBY-2_NP cells_NNS were_VBD found_VBN to_TO exhibit_VB 2-_CD to_TO 4-fold_NN increased_VBN HMGR_NP enzyme_NN activities_NNS compared_VBN with_IN control_NN cells_NNS ._SENT The_DT highest_JJS stimulation_NN rate_NN was_VBD observed_VBN at_IN 75_CD nm_NN ._SENT Such_PDT a_DT stimulation_NN of_IN HMGR_NP activity_NN could_MD be_VB detected_VBN as_RB early_RB as_IN 6_CD h_NN after_IN Sq_NP administration_NN and_CC progressively_RB increased_VBN until_IN 24_CD h_NN (_( Fig._NN A_NP )_) ._SENT For_IN northern-blot_NN experiments_NNS ,_, we_PP used_VBD as_IN a_DT probe_NN a_DT 1,400-bp_JJ fragment_NN corresponding_JJ to_TO the_DT C-terminal_JJ part_NN (_( catalytic_JJ site_NN )_) of_IN a_DT Nicotiana_NP sylvestris_NP HMGR_NP cDNA_NN ._SENT HMGR_NN transcripts_NNS with_IN a_DT size_NN of_IN about_RB 2.5_CD kb_NN could_MD be_VB detected_VBN ._SENT Figure_NP B_NP shows_VBZ a_DT dose-dependent_JJ increase_NN in_IN HMGR_NP mRNA_NP levels_NNS from_IN Sq-treated_NP TBY-2_NP cells_NNS ._SENT A_DT 5-fold_NN increase_NN was_VBD found_VBN in_IN cells_NNS treated_VBN with_IN 500_CD nm_NN Sq_NP ._SENT At_IN this_DT concentration_NN ,_, the_DT highest_JJS level_NN of_IN transcripts_NNS was_VBD observed_VBN 24_CD h_NN after_IN Sq_NP administration_NN (_( Fig._NN B_NN )_) ._SENT Taken_VBN together_RB ,_, these_DT results_NNS indicate_VBP that_IN the_DT inhibition_NN of_IN SQS_NP by_IN Sq_NP triggered_VBD a_DT stimulation_NN of_IN both_DT HMGR_NP steady-state_NN mRNA_NN and_CC enzyme_NN activity_NN ,_, suggesting_VBG that_IN the_DT arrest_NN of_IN sterol_NN biosynthesis_NN and_CC the_DT resulting_VBG depletion_NN of_IN squalene-derived_JJ products_NNS exerted_VBD a_DT positive_JJ feedback_NN regulatory_JJ effect_NN on_IN the_DT transcription_NN of_IN HMGR_NP ._SENT Surprisingly_RB ,_, this_DT inhibition_NN did_VBD not_RB activate_VB SQS_NP transcription_NN ._SENT Effect_NN of_IN Tb_NP |_SYM In_IN Vivo_NP Sterol_NP Biosynthesis_NP |_SYM Three-day-old_JJ TBY-2_NP cells_NNS were_VBD treated_VBN with_IN concentrations_NNS of_IN Tb_NP ranging_VBG from_IN 0_CD to_TO 30_CD mum_NN for_IN 30_CD h_NN ,_, then_RB collected_VBN by_IN filtration_NN and_CC analyzed_VBD for_IN their_PP$ free_JJ sterol_NN composition_NN as_RB described_VBD in_RP "_`` Materials_NPS and_CC Methods_NP ._SENT "_`` Squalene_NN and_CC free_JJ sterols_NNS (_( as_IN acetate_NN derivatives_NNS )_) were_VBD quantified_VBN by_IN GC_NP ._SENT Treatment_NN of_IN TBY-2_JJ cells_NNS with_IN Tb_NP was_VBD found_VBN to_TO induce_VB a_DT dose-dependent_JJ accumulation_NN of_IN squalene_NN and_CC a_DT progressive_JJ decrease_NN in_IN the_DT content_NN of_IN end_NN products_NNS (_( Fig._NN A_NP )_) ._SENT After_IN treatment_NN with_IN 30_CD mum_JJ Tb_NP ,_, the_DT squalene_NN content_NN amounted_VBD to_TO 5_CD mg_NN g-1_JJ dry_JJ weight_NN ,_, whereas_IN it_PP was_VBD barely_RB detectable_JJ in_IN control_NN cells_NNS (_( about_RB 20_CD mug_NN g-1_JJ dry_JJ weight_NN )_) ._SENT At_IN the_DT same_JJ time_NN ,_, the_DT remaining_VBG Delta5-sterols_NNS accounted_VBD for_IN only_RB 0.85_CD mg_NN g-1_JJ dry_JJ weight_NN compared_VBN with_IN 1.8_CD mg_NN g-1_NN for_IN control_NN cells_NNS ,_, corresponding_VBG approximately_RB to_TO a_DT 50_CD %_NN decrease_NN in_IN the_DT usual_JJ free_JJ sterol_NN content_NN ._SENT Such_PDT an_DT accumulation_NN of_IN squalene_NN clearly_RB indicates_VBZ an_DT inhibition_NN of_IN SE_NP by_IN Tb_NP ,_, leading_VBG to_TO an_DT arrest_NN of_IN end_NN product_NN biosynthesis_NN ._SENT No_DT change_NN in_IN relative_JJ proportions_NNS of_IN Delta5-sterols_NNS was_VBD found_VBN (_( data_NNS not_RB shown_VBN )_) ._SENT It_PP is_VBZ remarkable_JJ to_TO see_VB that_IN TBY-2_NP cells_NNS can_MD accommodate_VB such_JJ high_JJ squalene_NN intracellular_JJ concentrations_NNS because_IN no_DT inhibition_NN of_IN cell_NN growth_NN or_CC cell_NN death_NN was_VBD observed_VBN (_( data_NNS not_RB shown_VBN )_) ._SENT Figure_NP 5_CD |_SYM Effects_VBZ of_IN Tb_NP on_IN sterol_NN composition_NN (_( A_NP )_) and_CC biosynthesis_NN (_( B_NP )_) ._SENT Effects_NNS of_IN Tb_NP on_IN sterol_NN composition_NN (_( A_NP )_) and_CC biosynthesis_NN (_( B_NP )_) ._SENT Three-day-old_JJ TBY-2_NP cells_NNS were_VBD treated_VBN with_IN concentrations_NNS of_IN Tb_NP ranging_VBG from_IN 0_CD to_TO 30_CD mum_NN for_IN 24_CD h_NN and_CC incubated_VBN with_IN sodium_NN [_SYM 1-14C]acetate_JJ for_IN 2_CD h_NN before_IN cell_NN harvesting_NN ._SENT Sterols_NNS were_VBD extracted_VBN as_IN indicated_VBN in_IN "_`` Materials_NNS and_CC Methods_NNS ._SENT "_'' A_DT ,_, Squalene_NP and_CC free_JJ sterols_NNS (_( acetate_NN derivatives_NNS )_) were_VBD quantified_VBN by_IN GC_NP ._SENT Sterols_NNS amounts_NNS are_VBP expressed_VBN in_IN milligrams_NNS per_IN gram_NN dry_JJ weight_NN ._SENT B_NP ,_, Radioactivities_NP incorporated_VBD into_IN sterols_NNS and_CC precursors_NNS are_VBP expressed_VBN as_IN 105_CD cpm_NN g-1_JJ dry_JJ weight_NN (_( dwt_NN )_) ._SENT Figure_NN shows_VBZ a_DT time_NN course_NN of_IN squalene_NN accumulation_NN in_IN TBY-2_JJ cells_NNS treated_VBN with_IN 3_CD mum_JJ Tb_NP ._SENT A_DT significant_JJ increase_NN in_IN the_DT squalene_NN content_NN occurred_VBD as_RB soon_RB as_IN 6_CD h_NN after_IN administration_NN of_IN the_DT inhibitor_NN and_CC continued_VBD up_RP to_TO 48_CD h._NN After_IN 96_CD h_NN ,_, no_DT additional_JJ accumulation_NN of_IN squalene_NN was_VBD observed_VBN (_( data_NNS not_RB shown_VBN )_) ._SENT Figure_NP 6_CD |_SYM Time_NN course_NN of_IN squalene_NN accumulation_NN after_IN Tb_NP administration_NN ._SENT Time_NN course_NN of_IN squalene_NN accumulation_NN after_IN Tb_NP administration_NN ._SENT Three-day-old_JJ TBY-2_NP cells_NNS were_VBD treated_VBN by_IN 30_CD mum_NN of_IN Tb_NP for_IN different_JJ periods_NNS of_IN time_NN in_IN parallel_NN with_IN a_DT control_NN ._SENT Sterols_NNS were_VBD extracted_VBN as_IN indicated_VBN in_IN "_`` Materials_NNS and_CC Methods_NNS ._SENT "_'' Squalene_NN and_CC free_JJ sterols_NNS (_( acetate_NN derivatives_NNS )_) were_VBD quantified_VBN by_IN GC_NP ._SENT Sterol_NN amounts_NNS are_VBP expressed_VBN in_IN milligrams_NNS per_IN gram_NN dry_JJ weight_NN (_( dwt_NN )_) ._SENT Further_JJR evidence_NN for_IN the_DT SE_NP inhibition_NN was_VBD obtained_VBN by_IN feeding_VBG control_NN and_CC Tb-treated_JJ TBY-2_JJ cells_NNS with_IN [_SYM 14C]acetate_JJ for_IN 2_CD h_NN before_IN cell_NN harvesting_NN ._SENT In_IN control_NN cells_NNS ,_, most_JJS of_IN the_DT acetate_NN radioactivity_NN was_VBD incorporated_VBN into_IN free_JJ sterols_NNS ,_, whereas_IN in_IN Tb-treated_JJ cells_NNS ,_, squalene_NN was_VBD by_IN far_RB the_DT most_RBS labeled_VBN compound_NN (_( Fig._NN B_NN )_) ._SENT After_IN treatment_NN with_IN 3_CD mum_JJ Tb_NP ,_, about_RB 71_CD %_NN of_IN the_DT radioactivity_NN recovered_VBD in_IN the_DT sterol_NN branch_NN was_VBD already_RB associated_VBN with_IN squalene_NN ._SENT At_IN this_DT concentration_NN ,_, a_DT time-course_JJ study_NN of_IN squalene_NN biosynthesis_NN demonstrated_VBD that_IN the_DT highest_JJS rate_NN of_IN synthesis_NN was_VBD obtained_VBN after_IN 24_CD h_NN of_IN treatment_NN (_( data_NNS not_RB shown_VBN )_) ._SENT After_IN treatment_NN with_IN 30_CD mum_NN ,_, 97_CD %_NN of_IN the_DT radioactivity_NN was_VBD present_JJ in_IN squalene_NN and_CC only_RB 2_CD %_NN in_IN the_DT end_NN products_NNS ._SENT Cycloartenol_NP Accumulation_NP at_IN Low_NP Tb_NP Concentration_NP |_SYM As_RB shown_VBN in_IN Figure_NP ,_, treatment_NN of_IN TBY-2_JJ cells_NNS with_IN 3_CD mum_JJ Tb_NP was_VBD found_VBN to_TO induce_VB a_DT significant_JJ accumulation_NN of_IN 4,4-dimethylsterols_NNS ._SENT These_DT compounds_NNS were_VBD mainly_RB represented_VBN by_IN cycloartenol_NN and_CC 24-methylenecycloartanol_JJ ._SENT GC_NN analysis_NN of_IN the_DT corresponding_JJ acetate_NN derivatives_NNS indicated_VBD a_DT specific_JJ increase_NN in_IN the_DT cycloartenol_NN content_NN (_( data_NNS not_RB shown_VBN )_) ,_, suggesting_VBG that_IN SMT1_NP involved_VBD in_IN the_DT methylation_NN of_IN cycloartenol_NN to_TO give_VB 24-methylenecycloartanol_JJ might_MD be_VB down-regulated_JJ ._SENT To_TO get_VB more_JJR insight_NN into_IN this_DT process_NN ,_, TBY-2_NP cells_NNS were_VBD treated_VBN with_IN 3_CD mum_JJ Tb_NN for_IN periods_NNS of_IN time_NN from_IN 0_CD to_TO 48_CD h._NN A_DT 2-h_JJ pulse_NN of_IN radioactive_JJ acetate_NN was_VBD given_VBN just_RB before_IN cell_NN harvesting_NN ._SENT After_IN lipid_NN extraction_NN ,_, the_DT fraction_NN of_IN 4,4-dimethylsterols_NNS was_VBD analyzed_VBN in_IN more_JJR detail_NN ._SENT The_DT acetate_NN derivatives_NNS were_VBD separated_VBN on_IN AgNO3-impregnated_JJ thin-layer_NN chromatography_NN (_( TLC_NP )_) plates_NNS ._SENT Cycloartenol_NP and_CC 24-methylenecycloartanol_NP were_VBD eluted_VBN and_CC quantified_VBN by_IN GC_NP ,_, and_CC their_PP$ radioactivity_NN was_VBD measured_VBN by_IN scintillation_NN counting_NN ._SENT As_IN shown_VBN in_IN Figure_NP A_NP ,_, the_DT cycloartenol_NN content_NN of_IN treated_VBN cells_NNS was_VBD found_VBN to_TO increase_VB progressively_RB in_IN function_NN of_IN the_DT duration_NN of_IN contact_NN with_IN the_DT inhibitor_NN ._SENT In_IN contrast_NN ,_, cycloartenol_NN did_VBD not_RB accumulate_VB in_IN control_NN cells_NNS (_( Fig._NN A_NP )_) ._SENT As_IN a_DT consequence_NN ,_, the_DT radioactivity_NN associated_VBN with_IN cycloartenol_NN declined_VBD rapidly_RB in_IN control_NN cells_NNS ,_, whereas_IN in_IN treated_VBN cells_NNS ,_, cycloartenol_NN continued_VBD to_TO be_VB actively_RB synthesized_VBN for_IN as_RB long_JJ as_IN 24_CD h_NN (_( Fig._NN B_NN )_) ._SENT Whatever_WDT the_DT period_NN of_IN time_NN ,_, only_RB low_JJ amounts_NNS of_IN radioactivity_NN were_VBD detected_VBN in_IN 24-methylenecycloartanol_JJ ._SENT Figure_NP 7_CD |_SYM Time_NN course_NN of_IN content_NN (_( A_NP )_) and_CC biosynthesis_NN (_( B_NP )_) of_IN 4,4-dimethylsterols_NNS after_IN administration_NN of_IN 3_CD mum_JJ Tb_NP ._SENT Time_NN course_NN of_IN content_NN (_( A_NP )_) and_CC biosynthesis_NN (_( B_NP )_) of_IN 4,4-dimethylsterols_NNS after_IN administration_NN of_IN 3_CD mum_JJ Tb_NP ._SENT Three-day-old_JJ TBY-2_NP cells_NNS were_VBD treated_VBN with_IN 3_CD mum_JJ Tb_NN for_IN different_JJ periods_NNS of_IN time_NN and_CC incubated_VBN with_IN sodium_NN [_SYM 1-14C]acetate_JJ for_IN 2_CD h_NN before_IN cell_NN harvesting_NN ._SENT A_DT ,_, Levels_NP of_IN the_DT three_CD major_JJ 4,4-dimethylsterols_NNS were_VBD quantified_VBN by_IN GC_NP (_( acetate_NN derivatives_NNS )_) and_CC expressed_VBN in_IN micrograms_NNS per_IN gram_NN dry_JJ weight_NN ._SENT B_NP ,_, Radioactivities_NP incorporated_VBD into_IN cycloartenol_NN and_CC 24-methylenecycloartanol_JJ were_VBD expressed_VBN as_IN 105_CD cpm_NN g-1_JJ dry_JJ weight_NN (_( dwt_NN )_) ._SENT 24-me_JJ cycloartanol_NN ,_, 24-Methylenecycloartanol_JJ ._SENT To_TO investigate_VB whether_IN the_DT methylation_NN of_IN cycloartenol_NN by_IN the_DT SMT1_NP could_MD be_VB inhibited_VBN in_IN TBY-2_JJ cells_NNS treated_VBN by_IN low_JJ Tb_NP concentrations_NNS ,_, microsomal_JJ fractions_NNS were_VBD isolated_VBN from_IN control_NN and_CC Tb-treated_JJ cells_NNS and_CC tested_VBN for_IN their_PP$ SMT1_JJ enzyme_NN activities_NNS ._SENT Similar_JJ enzyme_NN activities_NNS were_VBD found_VBN (_( data_NNS not_RB shown_VBN )_) ,_, indicating_VBG that_IN the_DT SMT1_NP protein_NN remained_VBD active_JJ despite_IN the_DT Tb_NP treatment_NN of_IN tobacco_NN cells_NNS ._SENT We_PP also_RB checked_VBD that_IN 30_CD mum_JJ Tb_NP had_VBD no_DT direct_JJ inhibitory_JJ effect_NN on_IN SMT1_JJ activity_NN ._SENT Thus_RB ,_, these_DT data_NNS indicate_VBP that_IN the_DT inhibition_NN of_IN the_DT methylation_NN reaction_NN occurs_VBZ only_RB in_IN intact_JJ treated_VBN cells_NNS and_CC could_MD result_VB from_IN a_DT secondary_JJ regulatory_JJ effect_NN ._SENT SQS_NP and_CC HMGR_NP Expression_NP |_SYM As_RB stated_VBN above_IN ,_, treatment_NN of_IN TBY-2_JJ cells_NNS with_IN Tb_NP triggered_VBD the_DT accumulation_NN of_IN impressive_JJ amounts_NNS of_IN squalene_NN ,_, the_DT product_NN of_IN the_DT reaction_NN catalyzed_VBN by_IN SQS_NP ._SENT In_IN control_NN cells_NNS ,_, endogenous_JJ squalene_NN was_VBD barely_RB detectable_JJ ._SENT Despite_IN such_JJ large_JJ increases_NNS of_IN squalene_NN ,_, SQS_NP was_VBD found_VBN to_TO exhibit_VB a_DT constant_JJ enzyme_NN activity_NN ,_, similar_JJ to_TO that_DT of_IN control_NN cells_NNS and_CC whatever_WDT the_DT duration_NN of_IN the_DT Tb_NP treatment_NN (_( Fig._NN B_NN )_) ._SENT At_IN the_DT same_JJ time_NN ,_, no_DT significant_JJ change_NN in_IN the_DT SQS_NP steady-state_NN mRNA_NN levels_NNS was_VBD observed_VBN (_( Fig._NN C_NP )_) ,_, indicating_VBG no_DT negative_JJ regulatory_JJ effect_NN on_IN the_DT gene_NN transcription_NN by_IN squalene_NN ._SENT Figure_NP 8_CD |_SYM Time_NN course_NN of_IN Tb_NP effects_NNS on_IN HMGR_NP (_( A_NP )_) and_CC SQS_NP (_( B_NP )_) activities_NNS and_CC mRNA_NN levels_NNS (_( C_NP )_) ._SENT Time_NN course_NN of_IN Tb_NP effects_NNS on_IN HMGR_NP (_( A_NP )_) and_CC SQS_NP (_( B_NP )_) activities_NNS and_CC mRNA_NN levels_NNS (_( C_NP )_) ._SENT Three-day-old_JJ TBY-2_NP cells_NNS were_VBD treated_VBN for_IN various_JJ time_NN periods_NNS (_( from_IN 0_CD to_TO 48_CD h_NN )_) with_IN 30_CD mum_JJ Tb_NP and_CC used_VBN to_TO isolate_VB both_DT microsomal_JJ fractions_NNS and_CC total_JJ RNA_NP ._SENT A_DT ,_, HMGR_NP activity_NN was_VBD measured_VBN as_IN indicated_VBN in_IN Figure_NP ._SENT For_IN each_DT point_NN ,_, enzyme_NN activities_NNS were_VBD expressed_VBN as_IN relative_JJ values_NNS to_TO the_DT corresponding_JJ control_NN (_( set_VBN at_IN 1_CD )_) ._SENT Results_NNS are_VBP from_IN three_CD independent_JJ experiments_NNS +-_NN sd_NN ._SENT B_NP ,_, SQS_NP activity_NN was_VBD measured_VBN in_IN the_DT presence_NN of_IN [_SYM 1-3H]FPP_NP and_CC of_IN 10_CD mug_NN of_IN microsomal_JJ protein_NN ._SENT For_IN each_DT time_NN ,_, enzyme_NN activities_NNS were_VBD expressed_VBN as_IN relative_JJ values_NNS to_TO the_DT corresponding_JJ control_NN (_( set_VBN at_IN 1_CD )_) ._SENT Results_NNS are_VBP from_IN three_CD independent_JJ experiments_NNS +-_NN sd_NN ._SENT C_NP ,_, Total_NP RNA_NP (_( 30_CD mug_NN )_) was_VBD loaded_VBN per_IN lane_NN and_CC transferred_VBN to_TO a_DT nylon_NN membrane_NN ._SENT Hybridizations_NNS were_VBD performed_VBN with_IN 32P-labeled_JJ probes_NNS ._SENT All_PDT the_DT hybridizations_NNS were_VBD performed_VBN on_IN the_DT same_JJ membrane_NN ._SENT Relative_JJ intensities_NNS obtained_VBN by_IN PhosphorImage_NP analysis_NN are_VBP given_VBN in_IN the_DT table_NN after_IN correction_NN for_IN background_NN and_CC normalization_NN relative_JJ to_TO EF1-alpha_NP mRNA_NP content_NN and_CC compared_VBN with_IN the_DT corresponding_JJ control_NN (_( set_VBN at_IN 1_CD )_) ._SENT We_PP also_RB investigated_VBD effects_NNS of_IN Tb_NP treatments_NNS on_IN HMGR_NP expression_NN ._SENT As_IN shown_VBN in_IN Figure_NP A_NP ,_, a_DT 2-_CD to_TO 4-fold_JJ increase_NN in_IN the_DT HMGR_NP enzyme_NN activity_NN was_VBD observed_VBN in_IN TBY-2_JJ cells_NNS treated_VBN with_IN 30_CD mum_JJ Tb_NP ._SENT The_DT stimulation_NN occurred_VBD already_RB after_IN 6_CD h_NN and_CC reached_VBD a_DT maximum_NN after_IN 24_CD h._NN However_RB ,_, this_DT increase_NN in_IN enzyme_NN activity_NN was_VBD not_RB correlated_VBN with_IN significant_JJ modifications_NNS of_IN the_DT corresponding_JJ mRNA_NN levels_NNS (_( Fig._NN C_NP )_) ._SENT TAG_NN Synthesis_NN |_SYM Besides_IN the_DT accumulation_NN of_IN squalene_NN ,_, Tb_NP treatment_NN of_IN TBY-2_JJ cells_NNS also_RB triggered_VBD a_DT significant_JJ dose-dependent_NN increase_NN in_IN the_DT TAG_NP content_NN ,_, with_IN an_DT 8-fold_JJ enhancement_NN of_IN the_DT mean_JJ value_NN measured_VBN for_IN control_NN cells_NNS after_IN administration_NN of_IN 30_CD mum_NN ._SENT This_DT increase_NN directly_RB resulted_VBD from_IN a_DT stimulation_NN of_IN their_PP$ de_NP novo_NP biosynthetic_JJ rate_NN ,_, as_RB indicated_VBN by_IN the_DT parallel_JJ increase_NN in_IN their_PP$ [_SYM 14C]radioactivity_NN ._SENT A_DT concomitant_JJ accumulation_NN of_IN lipid_NN droplets_NNS in_IN the_DT cytosol_NN of_IN treated_VBN cells_NNS was_VBD found_VBN to_TO take_VB place_NN ._SENT Light_JJ microscopy_NN observations_NNS showed_VBD the_DT presence_NN of_IN many_JJ orange_JJ spheres_NNS after_IN staining_VBG of_IN cells_NNS with_IN Sudan_NP IV_NP ,_, a_DT lipid-specific_JJ dye_NN ._SENT Very_RB few_JJ or_CC none_NN of_IN these_DT lipid_NN droplets_NNS were_VBD seen_VBN in_IN control_NN cells_NNS ._SENT These_DT results_NNS suggest_VBP that_IN relationships_NNS between_IN sterol_NN and_CC TAG_NP biosynthetic_JJ pathways_NNS might_MD occur_VB in_IN vivo_RB ._SENT Table_NP III_NP |_SYM Effects_VBZ of_IN Tb_NP on_IN TAG_NP content_NN and_CC biosynthesis_NN Figure_NP 9_CD |_SYM Lipid_JJ particles_NNS in_IN the_DT cytosol_NN of_IN TBY-2_JJ cells_NNS treated_VBN with_IN Tb_NP ._SENT Lipid_NN particles_NNS in_IN the_DT cytosol_NN of_IN TBY-2_JJ cells_NNS treated_VBN with_IN Tb_NP ._SENT Three-day-old_JJ TBY-2_NP cells_NNS were_VBD treated_VBN for_IN 24_CD h_NN with_IN Tb_NP 30_CD mum_NN and_CC then_RB observed_VBN in_IN optical_JJ microscopy_NN after_IN staining_VBG by_IN Sudan_NP IV_NP ,_, in_IN parallel_NN with_IN a_DT control_NN ._SENT Lipid_NN particles_NNS appear_VBP as_IN spherical_JJ orange_JJ droplets_NNS ._SENT Bar_NN =_SYM 20_CD mum_NN ._SENT Squalene_NN Intracellular_NP Localization_NP |_SYM To_TO address_VB the_DT question_NN of_IN the_DT intracellular_JJ localization_NN of_IN the_DT overproduced_VBN squalene_NN ,_, TBY-2_NP cells_NNS were_VBD treated_VBN with_IN 30_CD mum_JJ Tb_NP for_IN 24_CD h_NN before_IN being_VBG used_VBN for_IN isolation_NN of_IN a_DT microsomal_JJ fraction_NN ._SENT After_IN sedimentation_NN at_IN 100,000g_NP ,_, lipid_NN particles_NNS appeared_VBD as_IN a_DT fluffy_JJ lipid_NN layer_NN at_IN the_DT surface_NN of_IN the_DT corresponding_JJ supernatant_JJ ._SENT Both_DT fractions_NNS were_VBD then_RB analyzed_VBN for_IN their_PP$ squalene_NN content_NN ._SENT In_IN control_NN cells_NNS ,_, squalene_NN could_MD be_VB not_RB detected_VBN in_IN the_DT supernatant_JJ ._SENT In_IN contrast_NN ,_, most_RBS (_( i.e._FW higher_JJR than_IN 90_CD %_NN )_) of_IN the_DT squalene_NN from_IN treated_VBN cells_NNS was_VBD recovered_VBN in_IN the_DT lipid_NN droplets_NNS ._SENT The_DT remaining_VBG 10_CD %_NN were_VBD associated_VBN with_IN the_DT microsomal_JJ fraction_NN ._SENT It_PP seemed_VBD to_TO us_PP interesting_JJ to_TO investigate_VB whether_IN or_CC not_RB the_DT squalene_NN stored_VBN in_IN these_DT lipid_NN particles_NNS could_MD be_VB reused_VBN as_IN a_DT precursor_NN for_IN sterol_NN biosynthesis_NN ._SENT TBY-2_JJ cells_NNS were_VBD first_RB treated_VBN with_IN 30_CD mum_JJ Tb_NP for_IN 24_CD h_NN and_CC fed_VBN with_IN radioactive_JJ acetate_NN for_IN 2_CD h_NN just_RB before_IN cell_NN harvesting_NN ._SENT They_PP were_VBD then_RB extensively_RB washed_VBN and_CC resuspended_VBN in_IN a_DT Murashige_NP and_CC Skoog_NP medium_NN containing_VBG 0.5_CD mum_JJ Sq_NP to_TO block_VB the_DT synthesis_NN of_IN endogenous_JJ squalene_NN ._SENT These_DT cells_NNS were_VBD allowed_VBN to_TO grow_VB for_IN 12_CD ,_, 24_CD ,_, and_CC 48_CD h_NN ,_, respectively_RB ,_, collected_VBN by_IN filtration_NN ,_, and_CC analyzed_VBD for_IN their_PP$ content_NN in_IN squalene_NN and_CC in_IN free_JJ sterols_NNS and_CC their_PP$ precursors_NNS (_( 4,4-dimethyl-_JJ and_CC 4alpha-methylsterols_JJ )_) ._SENT Radioactivity_NN associated_VBN with_IN each_DT class_NN of_IN compounds_NNS was_VBD also_RB measured_VBN ._SENT A_DT sample_NN of_IN TBY-2_JJ cells_NNS treated_VBN with_IN Tb_NP for_IN 24_CD h_NN was_VBD taken_VBN as_IN a_DT control_NN (_( t0h_NN )_) ._SENT As_IN shown_VBN in_IN Table_NP ,_, TBY-2_NP cells_NNS collected_VBN after_IN 12_CD and_CC 24_CD h_NN exhibited_VBN dramatic_JJ decreases_NNS in_IN both_CC the_DT content_NN and_CC radioactivity_NN of_IN squalene_NN ,_, whereas_IN concomitant_JJ and_CC similar_JJ increases_NNS were_VBD found_VBN for_IN the_DT sterol_NN end_NN products_NNS ._SENT A_DT 2-fold_JJ increase_NN in_IN the_DT level_NN of_IN 4-demethylsterols_NNS occurred_VBN after_IN 24_CD h_NN ,_, despite_IN the_DT inhibition_NN of_IN SQS_NP by_IN Sq_NP ,_, and_CC these_DT compounds_NNS contained_VBD the_DT most_JJS radioactivity_NN initially_RB associated_VBN with_IN squalene_NN ._SENT In_IN the_DT further_JJR 24_CD h_NN (_( t48h_NN )_) ,_, their_PP$ amount_NN was_VBD reduced_VBN by_IN 50_CD %_NN because_IN no_DT more_JJR squalene_NN was_VBD available_JJ ._SENT The_DT data_NNS from_IN Table_NP also_RB indicate_VBP a_DT transient_JJ increase_NN in_IN both_CC the_DT contents_NNS and_CC radioactivities_NNS of_IN the_DT sterol_NN biosynthetic_JJ precursors_NNS ,_, giving_VBG evidence_NN for_IN a_DT restart_VB of_IN an_DT active_JJ sterol_NN biosynthesis_NN from_IN the_DT pool_NN of_IN radioactive_JJ squalene_NN ,_, triggered_VBN by_IN the_DT Tb_NP removal_NN ._SENT Finally_RB ,_, it_PP should_MD be_VB emphasized_VBN that_IN such_PDT a_DT restoration_NN of_IN the_DT sterol_NN biosynthesis_NN was_VBD accompanied_VBN by_IN a_DT parallel_JJ decrease_NN in_IN the_DT content_NN and_CC radioactivity_NN of_IN TAG_NP ,_, indicating_VBG once_RB more_RBR likely_JJ relationships_NNS between_IN both_DT pathways_NNS ._SENT Taken_VBN together_RB ,_, these_DT results_NNS clearly_RB demonstrate_VBP that_DT squalene_NN ,_, which_WDT was_VBD previously_RB stored_VBN in_IN cytoplasmic_JJ lipid_NN particles_NNS ,_, could_MD be_VB remobilized_VBN for_IN an_DT active_JJ sterol_NN biosynthesis_NN ._SENT Even_RB if_IN the_DT fate_NN of_IN TAG_NP molecules_NNS remains_VBZ to_TO be_VB investigated_VBN ,_, it_PP appears_VBZ that_IN these_DT lipid_NN particles_NNS actually_RB do_VBP constitute_VB a_DT pool_NN of_IN available_JJ metabolic_JJ intermediates_NNS ._SENT Table_NP IV_NP |_SYM Redirection_NN of_IN squalene_NN from_IN lipid_NN particles_NNS to_TO the_DT sterol_NN pathway_NN In_IN contrast_NN to_TO the_DT situation_NN in_IN animal_JJ cells_NNS ,_, much_RB less_JJR is_VBZ known_VBN regarding_VBG regulation_NN of_IN the_DT sterol_NN pathway_NN in_IN plants_NNS ._SENT In_IN that_DT context_NN ,_, we_PP planned_VBD to_TO investigate_VB the_DT potential_JJ regulatory_JJ role_NN played_VBN by_IN the_DT plant_NN SQS_NP for_IN the_DT following_VBG reasons_NNS :_: (_( a_DT )_) SQS_NP is_VBZ the_DT first_JJ committed_JJ enzyme_NN to_TO the_DT sterol_NN branch_NN of_IN the_DT isoprenoid_JJ pathway_NN and_CC as_RB such_JJ ,_, may_MD play_VB a_DT critical_JJ role_NN in_IN directing_VBG FPP_NP molecules_NNS in_IN either_DT sterol_NN or_CC non-sterol_NN isoprenoids_NNS in_IN response_NN to_TO changing_VBG cellular_JJ requirements_NNS ;_: (_( b_LS )_) because_IN sterols_NNS are_VBP major_JJ isoprenoid_JJ end_NN products_NNS ,_, most_JJS part_NN of_IN precursors_NNS goes_VBZ through_IN SQS_NP ;_: (_( c_LS )_) SQS_NP has_VBZ been_VBN known_VBN to_TO participate_VB in_IN plant_NN defense_NN reactions_NNS against_IN pathogens_NNS ;_: and_CC (_( d_LS )_) in_IN mammalian_JJ cells_NNS ,_, SQS_NP is_VBZ coordinately_RB regulated_VBN with_IN HMGR_NP by_IN a_DT sterol_NN feedback_NN mechanism_NN ._SENT Moreover_RB ,_, inhibition_NN of_IN SQS_NP would_MD not_RB deprive_VB the_DT cell_NN of_IN important_JJ non-sterol_NN compounds_NNS such_JJ as_IN isoprenylated_JJ proteins_NNS ,_, dolichol_NN ,_, heme_NN a_DT ,_, or_CC ubiquinone_NN ._SENT As_IN a_DT plant_NN material_NN ,_, we_PP used_VBD tobacco_NN BY-2_NP cell_NN suspension_NN cultures_NNS ._SENT This_DT cell_NN line_NN was_VBD originally_RB selected_VBN for_IN its_PP$ very_RB short_JJ cell_NN cycle_NN (_( about_RB 15_CD h_NN ;_: )_) ._SENT Such_PDT a_DT suspension_NN was_VBD ,_, therefore_RB ,_, particularly_RB suitable_JJ for_IN metabolic_JJ studies_NNS and_CC labeling_VBG experiments_NNS ._SENT TBY-2_JJ cells_NNS were_VBD first_RB checked_VBN for_IN their_PP$ ability_NN for_IN sterol_NN synthesis_NN ._SENT As_IN shown_VBN in_IN Figure_NP ,_, SQS_NP and_CC SMT1_NP and_CC SMT2_NP enzyme_NN activities_NNS were_VBD expressed_VBN during_IN the_DT entire_JJ cell_NN growth_NN ,_, w_NN 